{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:40:51Z","timestamp":1776872451841,"version":"3.51.2"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.soncn.2025.151892","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:01:47Z","timestamp":1745866907000},"page":"151892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low-Risk Febrile Neutropenia Management: An Audit of Practice in a UK Cancer Center"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1560-1442","authenticated-orcid":false,"given":"Matthew","family":"Fowler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AnnMarie","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Affronti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.soncn.2025.151892_bib0001","unstructured":"Cancer Research UK. Cancer in the UK: overview 2023. 2023. Accessed January 24, 2023. https:\/\/www.cancerresearchuk.org\/sites\/default\/files\/cancer_in_the_uk_report-overview-03.pdf"},{"issue":"6","key":"10.1016\/j.soncn.2025.151892_bib0002","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(23)00183-3","article-title":"Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement","volume":"24","author":"Wilson","year":"2023","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.soncn.2025.151892_bib0003","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1470-2045(19)30284-0","article-title":"Global chemotherapy demands: a prelude to equal access","volume":"20","author":"Arnold","year":"2019","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.soncn.2025.151892_bib0004","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/oncolo\/oyac074","article-title":"Chemotherapy-induced neutropenia and febrile neutropenia in the US: a beast of burden that needs to be tamed?","volume":"27","author":"Boccia","year":"2022","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.soncn.2025.151892_bib0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00520-014-2459-x","article-title":"Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia","volume":"23","author":"Cort\u00e9s de Miguel","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soncn.2025.151892_bib0006","article-title":"Cancer inequalities in the United Kingdom and the data used to measure them: a scoping review","volume":"52","author":"Underwood","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"10.1016\/j.soncn.2025.151892_bib0007","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/S1470-2045(24)00345-0","article-title":"NHS cancer services and systems\u2014ten pressure points a UK cancer control plan needs to address","volume":"25","author":"Aggarwal","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soncn.2025.151892_bib0008","unstructured":"National Institute for Health and Clinical Excellence (NICE). Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients. CG151. 2012."},{"issue":"14","key":"10.1016\/j.soncn.2025.151892_bib0009","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.soncn.2025.151892_bib0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/archdischild-2021-323254","article-title":"Can I go home now? The safety and efficacy of a new UK paediatric febrile neutropenia protocol for risk-stratified early discharge on oral antibiotics","volume":"108","author":"Jackson","year":"2023","journal-title":"Arch Dis Child"},{"issue":"8","key":"10.1016\/j.soncn.2025.151892_bib0011","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/pbc.25012","article-title":"Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low-risk febrile neutropenia: a randomized trial","volume":"61","author":"Orme","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"25","key":"10.1016\/j.soncn.2025.151892_bib0012","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1200\/JCO.2005.03.9909","article-title":"Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications","volume":"24","author":"Klastersky","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.soncn.2025.151892_bib0013","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00520-012-1517-5","article-title":"Eliciting patients\u2019 preferences for outpatient treatment of febrile neutropenia: a discrete choice experiment","volume":"21","author":"Teuffel","year":"2013","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.soncn.2025.151892_bib0014","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/bjc.2011.101","article-title":"Cost effectiveness of outpatient treatment for febrile neutropenia in adult cancer patients","volume":"104","author":"Teuffel","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.soncn.2025.151892_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.52964\/AMJA.0742","article-title":"Early supported discharge for patients with febrile neutropenia \u2013 experience at a large district hospital in the UK","volume":"18","author":"Brunner","year":"2019","journal-title":"Acute Med"},{"issue":"1","key":"10.1016\/j.soncn.2025.151892_bib0016","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jemermed.2022.10.010","article-title":"Can risk stratification tools be utilized to safely discharge low-risk febrile neutropenic patients from the emergency department?","volume":"64","author":"Chen","year":"2023","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.soncn.2025.151892_bib0017","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/ash.2022.353","article-title":"Going local: evaluating guideline adherence and appropriateness of antibiotic prescribing in patients with febrile neutropenia at an academic teaching hospital","volume":"3","author":"Liu","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"3","key":"10.1016\/j.soncn.2025.151892_bib0018","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jemermed.2019.09.032","article-title":"Emergency ambulatory management of low-risk febrile neutropenia: multinational association for supportive care in cancer fits\u2014real-world experience from a UK cancer centre","volume":"58","author":"Marshall","year":"2020","journal-title":"J Emerg Med"},{"key":"10.1016\/j.soncn.2025.151892_bib0019","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s00520-018-4157-6","article-title":"A cohort study on protocol-based nurse-led outpatient management of post-chemotherapy low-risk febrile neutropenia","volume":"26","author":"Ying","year":"2018","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.soncn.2025.151892_bib0020","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1007\/s00520-018-4194-1","article-title":"A novel approach to improving ambulatory outpatient management of low-risk febrile neutropenia: an enhanced supportive care (ESC) clinic","volume":"26","author":"Cooksley","year":"2018","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.soncn.2025.151892_bib0021","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00520-023-08065-y","article-title":"Ambulatory management of low-risk febrile neutropenia in adult oncological patients. Systematic review","volume":"31","author":"Forcano-Queralt","year":"2023","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.soncn.2025.151892_bib0022","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JCO.2014.57.2347","article-title":"Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study","volume":"33","author":"Carmona-Bayonas","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.soncn.2025.151892_bib0023","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cmi.2023.07.021","article-title":"Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial","volume":"30","author":"Coyle","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.soncn.2025.151892_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102922","volume":"149","author":"Zheng","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"suppl 5","key":"10.1016\/j.soncn.2025.151892_bib0025","first-page":"1465","article-title":"Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents","volume":"26","author":"Ahn","year":"2018","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.soncn.2025.151892_bib0026","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/cancers17050828","article-title":"Perceived gaps in oncologic emergency care for patients with cancer: a qualitative comparison of emergency medicine and oncologist physician perspectives","volume":"17","author":"Wattana","year":"2025","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.soncn.2025.151892_bib0027","doi-asserted-by":"crossref","first-page":"3925+","DOI":"10.1007\/s00520-022-06820-1","article-title":"Barriers and facilitators for shared decision-making in oncology inpatient practice: an explorative study of the healthcare providers\u2019 perspective","volume":"30","author":"Steenbergen","year":"2022","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.soncn.2025.151892_bib0028","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: towards more accurate diagnoses","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2025.151892_bib0029","unstructured":"Nursing & Midwifery Council. The code: professional standards of practice and behaviour for nurses, midwives and nursing associates. 2018."},{"issue":"3","key":"10.1016\/j.soncn.2025.151892_bib0030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00520-014-2553-0","article-title":"Mortality, length of stay, and health care costs of febrile neutropenia-related hospitalizations among patients with breast cancer in the United States","volume":"23","author":"Pathak","year":"2015","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.soncn.2025.151892_bib0031","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/j.cllc.2017.10.013","article-title":"Analysis of factors associated with in-hospital mortality in lung cancer chemotherapy patients with neutropenia","volume":"19","author":"Cupp","year":"2018","journal-title":"Clin Lung Cancer"},{"issue":"30","key":"10.1016\/j.soncn.2025.151892_bib0032","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1200\/JCO.2011.37.5758","article-title":"No place like home? Outpatient management of patients with febrile neutropenia and low risk","volume":"29","author":"Freifeld","year":"2011","journal-title":"J Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.soncn.2025.151892_bib0033","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.e18000","article-title":"Potential length of stay reduction with outpatient management of low-risk febrile neutropenia in a regional cancer centre","volume":"37","author":"Nguyen","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.soncn.2025.151892_bib0034","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/17512433.2021.1884067","article-title":"Treatment of infections in cancer patients: an update from the neutropenia, infection and myelosuppression study group of the Multinational Association for Supportive Care in Cancer (MASCC)","volume":"14","author":"Rapoport","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.soncn.2025.151892_bib0035","first-page":"26","article-title":"MASCC vs CISNE scores comparison in febrile neutropenia: which is better?","volume":"13","author":"Boppana","year":"2023","journal-title":"Int J Med Public Health"},{"issue":"3","key":"10.1016\/j.soncn.2025.151892_bib0036","doi-asserted-by":"crossref","first-page":"118","DOI":"10.38175\/phnx.992230","article-title":"Scoring systems identifying the low-risk febrile neutropenia patients in the emergency department: usefulness of MASCC, CISNE and qSOFA","volume":"3","author":"Ipekci","year":"2021","journal-title":"Phoenix Med J"},{"key":"10.1016\/j.soncn.2025.151892_bib0037","article-title":"Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event","volume":"3","author":"Rivas-Ruiz","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.soncn.2025.151892_bib0038","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajem.2021.07.008","article-title":"Emergency department management of chemotherapy related febrile neutropenia: an opportunity to improve care","volume":"50","author":"Pettit","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"11","key":"10.1016\/j.soncn.2025.151892_bib0039","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.ajem.2019.09.016","article-title":"CISNE versus MASCC: identifying low-risk febrile neutropenic patients","volume":"38","author":"Mohindra","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"8","key":"10.1016\/j.soncn.2025.151892_bib0040","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: towards more accurate diagnoses","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.soncn.2025.151892_bib0041","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing\u2014when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J Clini Epidemiol"},{"issue":"3","key":"10.1016\/j.soncn.2025.151892_bib0042","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4300\/JGME-D-11-00147.1","article-title":"Getting off the \u201cgold standard\u201d: randomized controlled trials and education research","volume":"3","author":"Sullivan","year":"2011","journal-title":"J Grad Med Educ"},{"issue":"5","key":"10.1016\/j.soncn.2025.151892_bib0043","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","author":"Button","year":"2013","journal-title":"Nat Rev Neurosci"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208125000853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208125000853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T01:03:41Z","timestamp":1748653421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208125000853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0749208125000853"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2025.151892","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-Risk Febrile Neutropenia Management: An Audit of Practice in a UK Cancer Center","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2025.151892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151892"}}